Braakhuis BJ - Search Results

1

Addition of leucovorin in modulation of 5-fluorouracil with methotrexate: potentiating or reversing effect?

Van der Wilt CL, Braakhuis BJ, Pinedo HM, De Jong M, Smid K, Peters GJ. Van der Wilt CL, et al. Among authors: braakhuis bj. Int J Cancer. 1995 May 29;61(5):672-8. doi: 10.1002/ijc.2910610514. Int J Cancer. 1995. PMID: 7768641

2

Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.

Kroep JR, Loves WJ, van der Wilt CL, Alvarez E, Talianidis I, Boven E, Braakhuis BJ, van Groeningen CJ, Pinedo HM, Peters GJ. Kroep JR, et al. Among authors: braakhuis bj. Mol Cancer Ther. 2002 Apr;1(6):371-6. Mol Cancer Ther. 2002. PMID: 12477049

3

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.

Peters GJ, Braakhuis BJ, de Bruijn EA, Laurensse EJ, van Walsum M, Pinedo HM. Peters GJ, et al. Among authors: braakhuis bj. Br J Cancer. 1989 Mar;59(3):327-34. doi: 10.1038/bjc.1989.65. Br J Cancer. 1989. PMID: 2522792 Free PMC article.

4

The interval between methotrexate and leucovorin determines the efficacy of 5-fluorouracil modulation in vitro and in vivo.

van der Wilt CL, de Jong M, Braakhuis BJ, Pinedo HM, Peters GJ. van der Wilt CL, et al. Among authors: braakhuis bj. Adv Exp Med Biol. 1993;338:609-12. doi: 10.1007/978-1-4615-2960-6_125. Adv Exp Med Biol. 1993. PMID: 8304191 No abstract available.

5

In vitro antitumour activity of cis- and trans-5-fluoro-5,6-dihydro-6-alkoxy-uracils; effects on thymidylate synthesis.

van der Wilt CL, Visser GW, Braakhuis BJ, Wedzinga R, Noordhuis P, Smid K, Peters GJ. van der Wilt CL, et al. Among authors: braakhuis bj. Br J Cancer. 1993 Oct;68(4):702-7. doi: 10.1038/bjc.1993.413. Br J Cancer. 1993. PMID: 8398696 Free PMC article.

6

Schedule-dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts.

Braakhuis BJ, Ruiz van Haperen VW, Welters MJ, Peters GJ. Braakhuis BJ, et al. Eur J Cancer. 1995 Dec;31A(13-14):2335-40. doi: 10.1016/0959-8049(95)00419-x. Eur J Cancer. 1995. PMID: 8652266

7

Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors.

Veerman G, Ruiz van Haperen VW, Vermorken JB, Noordhuis P, Braakhuis BJ, Pinedo HM, Peters GJ. Veerman G, et al. Among authors: braakhuis bj. Cancer Chemother Pharmacol. 1996;38(4):335-42. doi: 10.1007/s002800050492. Cancer Chemother Pharmacol. 1996. PMID: 8674156

8

Antitumor activity of brequinar sodium (Dup-785) against human head and neck squamous cell carcinoma xenografts.

Braakhuis BJ, van Dongen GA, Peters GJ, van Walsum M, Snow GB. Braakhuis BJ, et al. Cancer Lett. 1990 Feb;49(2):133-7. doi: 10.1016/0304-3835(90)90149-r. Cancer Lett. 1990. PMID: 2306706

9

Fluoropyrimidine metabolism in human head and neck cancer xenografts and murine colon tumors.

Laurensse EJ, Braakhuis BJ, Pinedo HM, Peters GJ. Laurensse EJ, et al. Among authors: braakhuis bj. Adv Exp Med Biol. 1989;253B:327-34. doi: 10.1007/978-1-4684-5676-9_48. Adv Exp Med Biol. 1989. PMID: 2532861 No abstract available.

10

Schedule-dependent antitumor effect of gemcitabine in in vivo model system.

Braakhuis BJ, Ruiz van Haperen VW, Boven E, Veerman G, Peters GJ. Braakhuis BJ, et al. Semin Oncol. 1995 Aug;22(4 Suppl 11):42-6. Semin Oncol. 1995. PMID: 7481844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters